Intervention not reported
Cohort studies postexposure prophylaxis · children 9 months to 15 years old
The intervention may leads to lower cohort studies postexposure prophylaxis (low certainty).
1 finding from 1 review
Duration of antibiotic therapy · antibiotic use in acute respiratory infections
1 finding from 1 review
Rubella cases Initial meta‐analysis ‐ clinical diagnosis or serology +/‐ virus isolation +/‐ clinical signs · susceptible people exposed to rubella
Gamma‐globulin probably leads to lower rubella cases Initial meta‐analysis ‐ clinical diagnosis or serology… compared with control (saline or no treatment) (moderate certainty).
1 finding from 1 review
Subgroup: rubella cases Estimated dose 0.027 to 0.037 ml/lb11 Clinical diagnosis by 2 physicians · susceptible people exposed to rubella
Gamma‐globulin showed no clear difference in subgroup: rubella cases Estimated dose 0.027 to 0.037 ml/lb11… compared with control (saline or no treatment) (low certainty).
1 finding from 1 review
Subgroup: rubella cases Estimated dose 0.1 to 0.15 ml/lb11 Serology +/‐ virus isolation +/‐ clinical signs · susceptible people exposed to rubella
Gamma‐globulin leads to lower subgroup: rubella cases Estimated dose 0.1 to 0.15 ml/lb11 Serology… compared with control (saline or no treatment) (high certainty).
1 finding from 1 review
Subgroup: rubella cases Estimated dose 0.2 to 0.5 ml/lb11 Serology +/‐ virus isolation +/‐ clinical signs · susceptible people exposed to rubella
Gamma‐globulin showed no clear difference in subgroup: rubella cases Estimated dose 0.2 to 0.5 ml/lb11 Serology… compared with control (saline or no treatment) (moderate certainty).
1 finding from 1 review
Cases of congenital rubella infection ‐ not measured · susceptible people exposed to rubella
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cases of congenital rubella syndrome ‐ not measured · susceptible people exposed to rubella
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not measured · susceptible people exposed to rubella
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Measles cases ‐ convalescent serum · susceptible people exposed to measles
Immunoglobulin probably leads to lower measles cases ‐ convalescent serum compared with no treatment (moderate certainty).
1 finding from 1 review
Adverse events · susceptible children exposed to measles
1 finding from 1 review
Measles cases ‐ adult serum · susceptible people exposed to measles
Immunoglobulin probably leads to lower measles cases ‐ adult serum compared with no treatment (moderate certainty).
1 finding from 1 review
Measles cases ‐ gamma globulin · susceptible people exposed to measles
Immunoglobulin probably leads to lower measles cases ‐ gamma globulin compared with no treatment (moderate certainty).
1 finding from 1 review
Mortality due to measles · susceptible people exposed to measles
Immunoglobulin leads to lower mortality due to measles compared with no treatment (high certainty).
1 finding from 1 review
Complications due to measles · susceptible people exposed to measles
Immunoglobulin probably leads to lower complications due to measles compared with no treatment (moderate certainty).
1 finding from 1 review
Adverse events · susceptible people exposed to measles
1 finding from 1 review
Measles cases · susceptible children exposed to measles
Gamma globulin leads to lower measles cases compared with serum (high certainty).
1 finding from 1 review
Mortality due to measles · susceptible children exposed to measles
1 finding from 1 review
Complications due to measles · susceptible children exposed to measles
1 finding from 1 review